Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab

Daniel Y. Wang, Mahwesh Saleem, Bosco A. Paes, Ian Mitchell, Abby Li, Krista L. Lanctôt
2019 The Pediatric Infectious Disease Journal  
This study aimed to examine the risk of respiratory-related hospitalization in children with neurologic and muscular disorders (NMDs) who received respiratory syncytial virus (RSV) prophylaxis in the Canadian RSV Evaluation Study of Palivizumab.
doi:10.1097/inf.0000000000002297 pmid:30985509 fatcat:lrwhdew4wrcllmvsxhjp5ezaiq